QTT - Chinese news app, good user growth, should have enough cash for the time being - Lock up expires March 14, 2019, 2-3 day rest pattern

CTK - Chinese tech company, recent IPO, should have enough cash, thin and volatile, would have to use 10.50 risk and keep position size small

APYX - medical device company, played this one when it was Bovie Medical (BVX), changed name as a rebranding and moved from NYSE to NASDAQ, just beat on earnings and provided good guidance, strong balance sheet according to management, CHART rules apply, currently at 52-week highs

VCYT - genomic diagnostic company, jumped 40% on earnings, then pulled back with the market, went slow sto 20, and now its RSI 70 and at 52-week highs, did a raise in July 2018, their burn rate for three months is $2.5million and they have $77million in cash, so I think a raise is unlikely UPDATE: I would want to see it continue up today

HYRE - Uber/Lyft play, this company offers vehicle owners a chance to rent their cars to the ride sharing platforms, recent IPO, should have enough cash, downtrended since IPO but could be coming back now, watch for the chart to build for now

INSG - 5G play, all three charts, 52-week breakout, 4.2 million warrants with exercise price of $2.52 unlock on February 6, 2019, then there's another 16 million shares that the company can use to raise cash at any time, shelf already filed, I'd rather wait for lockup to expire and short when I know selling pressure is going to come in

FUV - SWING fun utility vehicle, we know this one from last year, the CEO bought $400k worth of shares recently, and the company just announced that they secured financing and plan to deliver the first commercially available EV in Q1 this year, the capital raise was done at $3 with warrants to purchase at $3.50

AEZS - licensing deal for their growth hormone test, say they have enough cash for now, but this is a chart play, watching for now

GSIT - semiconductors, raised guidance, earnings will be announced January 31 at market close, plenty of cash

RFL - commercial real estate holdings and pharmaceutical drugs, just received orphan drug designation and initiated phase II trials, plenty of cash, chart rules apply

LCI - don't care about the company, Guy Gentile owns 3.3 millions shares, unless he's been unloading at current levels, I reckon his average is somewhere in the 5-6 range, so we can estimate where he'll be selling if he starts getting under water, if he's smart he's been selling at current levels, but he may be holding on to some shares and he does have a little bit of a following, so I expect selling pressure, short once chart rules are lost

UROV - lockup period for 2.6 million shares expires sometime around March 2019, but the exercise price is $14, IPO'd at maybe the worst possible time, end of September, now coming back, should have plenty of cash, my thesis is this just got unjustifiably beaten down with the overall markets, could have a big bounce here, low float 10 million shares

CDLX - marketing solutions company, raised guidance, say they have enough cash, Chart rules apply

MKGI - literally state they need to raise cash imminently as they do not have enough to meet current short term obligations